5.440
−6,53%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +368.9% | +154.2% | 3 / 3 | +14.1% | +3.05 pp | +4.55 pp | +9.9% | 0.25 | 5.75 | 521 | +14,1% | 27,9 | +650,1% | 5.75 | 14.39 | −60,1% |
| Pts | 12 | 12 | 12 | 4 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 5.440 (close price on 2026-10-19)EPS (TTM): 946,8
Financial charts
1.Revenue & growth
VND bn521Q2/26
1.Revenue & growth
VND bn521Q2/26
2.Profit & growth
VND bn23,5Q2/26
3.Profit mix (Penman)
VND bn71,2Q2/26
4.Margins & cost structure
%18.2%Q2/26
5.Returns & cash cycle
% · days7.1%Q2/26
6.Earnings quality & cash
VND bn306Q2/26
7.Asset structure
VND bn1.511Q2/26
8.Funding & debt health
VND bn · times1.511Q2/26
9.Revenue backlog
VND bn8,77Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %508Q2/26
Adjusted EPS growth, latest quarter
369%
Average adjusted EPS growth, 3 quarters
154%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26